Shah C, Vicini FA. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management, and risk reduction strategies. Int J Radiat Oncol Biol Phys. 2011;81:907–14.

Article  Google Scholar 

Alcorso J, Sherman KA, Koelmeyer L, Mackie H, Boyages J. Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema. Support Care Cancer 2016; 24.

Shah C, Arthur DW, Wazer D, Khan A, Ridner S, Vicini F. The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review. Cancer Med. 2016;5(6):1154–62.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  Google Scholar 

Ridner SH, Dietrich MS, Boyages J, et al. A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention. Lymphat Res Biol 2022 Jan 28 [Epub ahead of print].

Boccardo FM, Ansaldi F, Bellini C, et al. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology. 2009;42(1):1–9.

CAS  PubMed  Google Scholar 

Torres Lacomba M, Yuste Sanchez MJ, ZapicoGoni A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised single blinded clinical trial. BMJ. 2010;340:b5396.

Article  Google Scholar 

Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat. 2002;75(1):51–64.

Article  Google Scholar 

Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol. 2014;12(4):289–94.

Article  Google Scholar 

Yang EJ, Ahn S, Kim EK, et al. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience. Breast Cancer Res Treat. 2016;160(2):269–76.

Article  Google Scholar 

Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34(1):2–11.

CAS  PubMed  Google Scholar 

Whitworth PW, Shah C, Vicini F, Cooper A. Preventing breast cancer-related lymphedema in high-risk patients: the impact of a structured surveillance protocol using bioimpedance spectroscopy. Front Oncol. 2018;8:197.

Article  Google Scholar 

Koelmeyer LA, Moloney E, Boyages J, Sherman KA, Dean CM. Prospective surveillance model in the home for breast cancer-related lymphoedema: a feasibility study. Breast Cancer Res Treat. 2021;185(2):401–12.

Article  Google Scholar 

Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19.

Article  Google Scholar 

StoutGergich NLPL, Levy E, McGarvey CL, Gerber L, Springer B, Soballe P. Five year preliminary outcomes of a prospective surveillance model to reduce upper extremity morbidity related to breast cancer treatment. Cancer Res. 2011;71(24):1s–653s.

Google Scholar 

Gerber LH, Stout NL, Schmitz KH, Stricker CT. Integrating a prospective surveillance model for rehabilitation into breast cancer survivorship care. Cancer. 2012;118(8 Suppl):2201–6.

Article  Google Scholar 

Rafn BS, Christensen J, Larsen A, et al. Prospective surveillance for breast cancer-related arm lymphedema: a systematic review and meta-analysis. J Clin Oncol. 2022;40:1009–26.

Article  Google Scholar 

Chen YW, Tsai HJ, Hung HC, et al. Reliability study of measurements for lymphedema in breast cancer patients. Am J Phys Med Rehabil. 2008;87:33–8.

Article  Google Scholar 

Bilir SP, DeKoven MP, Munakata J. Economic benefits of BIS-aided assessment of post-BC lymphedema in the United States. Am J Manag Care. 2012;18(5):234–41.

PubMed  Google Scholar 

Shah C. Bioimpedance spectroscopy in the detection of breast cancer-related lymphedema: an ounce of prevention. Breast J. 2019;25(6):1323–5.

Article  Google Scholar 

Koelmeyer L, Gaitatzis K, Ridner SH, et al. Implementing a prospective surveillance and early intervention model of care for breast cancer–related lymphedema into clinical practice: application of the RE-AIM framework. Support Care Cancer 2021;29(2):1081–89.

NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.2.2022. 2022. Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed June 1 2022.

NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship V.3.2021. 2021. Available at: https://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf. Accessed June 1 2022.

Levenhagen K, Davies K, Perdomo M, et al. Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the Oncology Section of the American Physical Therapy Association. Phys Ther. 2017;97:729–45.

Article  Google Scholar 

Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007–14.

Article  Google Scholar 

Stout NL, Pfalzer LA, Springer B, et al. Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther. 2012;92(1):152–63.

Article  Google Scholar 

Paramanandam VS, Dylke E, Clark GM, et al. Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer-related lymphedema: a randomized controlled trial. J Clin Oncol 2022 [Epub ahead of print].